U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07361926) titled 'Sexual Health Access at Retail Pharmacies: Advancing Pharmacy-based Delivery of Primary STI and HIV Prevention for Cisgender Women' on Jan. 21.

Brief Summary: This proposed 3-arm randomized study will compare different pharmacy based approaches that include HIV prevention medication (PrEP and PEP), routine STI testing, and preventive antibiotic (doxycycline) for STIs. The study will assess how well these services can be implemented, how acceptable they are to young women, and whether they are cost-effective.

Study Start Date: May, 2026

Study Type: INTERVENTIONAL

Condition: Sexually Transmitted Infections (Not HIV or Hepatitis) H...